Retatrutide

- Triple-Agonist: GIP, GLP-1, and Glucagon receptor
- Available in 10mg to 50mg dosages
- Extensive clinical research data
- Lyophilized powder for optimal stability
- >=99% purity with batch documentation
- Temperature-controlled shipping

Retatrutide (research code LY3437943) is a cutting-edge research peptide and a novel next-generation triple agonist. It is the first molecule of its class retatrutide buy reta to highly selectively and simultaneously bind to three crucial metabolic receptors: the GIP receptor (glucose-dependent insulinotropic polypeptide), the GLP-1 receptor (glucagon-like peptide-1), and the Glucagon receptor (GCG-R).